Picture of Unicycive Therapeutics logo

UNCY — Unicycive Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSmall Cap

US FDA declines to approve Unicycive's drug for dialysis patients

US FDA declines to approve Unicycive's drug for dialysis patients

- The U.S. Food and Drug Administration declined to approve Uniycive Therapeutics' UNCY.O drug to treat elevated phosphate levels in chronic kidney disease patients on dialysis, the company said on Tuesday.


(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shinjini Ganguli)

((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on Unicycive Therapeutics

See all news